Impact of Body Mass Index (BMI) on the Effect of a Lactobacillus Rhamnosus GG (LGG)/Bifidobacterium Animalis Subspecies Lactis BB-12 (BB-12) Combination on Gut Microbiota (P20-023-19)
This exploratory study builds upon an earlier study of probiotic supplementation1 to assess the effects of a probiotic combination (P) of LGG and BB-12 on human gut microbiota composition and function, and to uncover an association with BMI. Healthy subjects ingested P for 21 days (n = 18, P group)...
Saved in:
Published in | Current developments in nutrition Vol. 3; no. Supplement_1; p. nzz040.P20-023-19 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.06.2019
Oxford University Press |
Subjects | |
Online Access | Get full text |
ISSN | 2475-2991 2475-2991 |
DOI | 10.1093/cdn/nzz040.P20-023-19 |
Cover
Loading…
Abstract | This exploratory study builds upon an earlier study of probiotic supplementation1 to assess the effects of a probiotic combination (P) of LGG and BB-12 on human gut microbiota composition and function, and to uncover an association with BMI.
Healthy subjects ingested P for 21 days (n = 18, P group) or did not (n = 7, C group).
Fecal samples obtained at baseline (D_0) and after 21 days of supplementation (D_21) underwent 16S ribosomal RNA gene and shotgun metagenomics sequencing to characterize the bacterial and archaeal communities to the genus/species level and identify functional community genes.
Following P ingestion, no global differences in microbiota community structure or relative gene abundance were detected. In targeted analyses, the abundances of LGG and BB-12 in the P group at D_21 increased in a statistically significant manner as the BMI decreased (Spearman correlation, P = 0.04 and P = 0.01, respectively). The relative abundance of LGG but not BB-12 appeared increased in P subjects at D_21 with BMI < 25 compared to BMI > 25 (P = 0.09). P group subjects with BMI < 25 demonstrated trends toward or statistically significant increases in the relative abundances of 5 genes involved with flagellar structure (KEGG orthologs K02422, P = 0.04; K03406, P = 0.06; K02407, P = 0.08; K02397, P = 0.08; K02396, P = 0.09) at D_21 compared to those with BMI > 25. No such differences were observed for the C group nor were there differences in relative gene abundance at D_0 in the P group with BMI < 25 vs BMI > 25.
We observed no global changes in the fecal microbial community structure or function with P ingestion in this sample of healthy persons. However, we did observe patterns suggestive of a potential link between BMI and the response of the gut microbiota to P. Although our results are based on a small number of subjects, they are in line with previous findings related to LGG supplementation and the expression of flagellar genes2. We agree with other recent reports that future studies would benefit from a detailed examination of the transcriptome, proteome and/or metabolome to better understand the potential impact of probiotics on the gut microbiota, and the mechanism of the effect of BMI.
Pfizer Inc. |
---|---|
AbstractList | This exploratory study builds upon an earlier study of probiotic supplementation1 to assess the effects of a probiotic combination (P) of LGG and BB-12 on human gut microbiota composition and function, and to uncover an association with BMI.
Healthy subjects ingested P for 21 days (n = 18, P group) or did not (n = 7, C group).
Fecal samples obtained at baseline (D_0) and after 21 days of supplementation (D_21) underwent 16S ribosomal RNA gene and shotgun metagenomics sequencing to characterize the bacterial and archaeal communities to the genus/species level and identify functional community genes.
Following P ingestion, no global differences in microbiota community structure or relative gene abundance were detected. In targeted analyses, the abundances of LGG and BB-12 in the P group at D_21 increased in a statistically significant manner as the BMI decreased (Spearman correlation, P = 0.04 and P = 0.01, respectively). The relative abundance of LGG but not BB-12 appeared increased in P subjects at D_21 with BMI < 25 compared to BMI > 25 (P = 0.09). P group subjects with BMI < 25 demonstrated trends toward or statistically significant increases in the relative abundances of 5 genes involved with flagellar structure (KEGG orthologs K02422, P = 0.04; K03406, P = 0.06; K02407, P = 0.08; K02397, P = 0.08; K02396, P = 0.09) at D_21 compared to those with BMI > 25. No such differences were observed for the C group nor were there differences in relative gene abundance at D_0 in the P group with BMI < 25 vs BMI > 25.
We observed no global changes in the fecal microbial community structure or function with P ingestion in this sample of healthy persons. However, we did observe patterns suggestive of a potential link between BMI and the response of the gut microbiota to P. Although our results are based on a small number of subjects, they are in line with previous findings related to LGG supplementation and the expression of flagellar genes2. We agree with other recent reports that future studies would benefit from a detailed examination of the transcriptome, proteome and/or metabolome to better understand the potential impact of probiotics on the gut microbiota, and the mechanism of the effect of BMI.
Pfizer Inc. This exploratory study builds upon an earlier study of probiotic supplementation¹ to assess the effects of a probiotic combination (P) of LGG and BB-12 on human gut microbiota composition and function, and to uncover an association with BMI. Healthy subjects ingested P for 21 days (n = 18, P group) or did not (n = 7, C group). Fecal samples obtained at baseline (D_0) and after 21 days of supplementation (D_21) underwent 16S ribosomal RNA gene and shotgun metagenomics sequencing to characterize the bacterial and archaeal communities to the genus/species level and identify functional community genes. Following P ingestion, no global differences in microbiota community structure or relative gene abundance were detected. In targeted analyses, the abundances of LGG and BB-12 in the P group at D_21 increased in a statistically significant manner as the BMI decreased (Spearman correlation, P = 0.04 and P = 0.01, respectively). The relative abundance of LGG but not BB-12 appeared increased in P subjects at D_21 with BMI < 25 compared to BMI > 25 (P = 0.09). P group subjects with BMI < 25 demonstrated trends toward or statistically significant increases in the relative abundances of 5 genes involved with flagellar structure (KEGG orthologs K02422, P = 0.04; K03406, P = 0.06; K02407, P = 0.08; K02397, P = 0.08; K02396, P = 0.09) at D_21 compared to those with BMI > 25. No such differences were observed for the C group nor were there differences in relative gene abundance at D_0 in the P group with BMI < 25 vs BMI > 25. We observed no global changes in the fecal microbial community structure or function with P ingestion in this sample of healthy persons. However, we did observe patterns suggestive of a potential link between BMI and the response of the gut microbiota to P. Although our results are based on a small number of subjects, they are in line with previous findings related to LGG supplementation and the expression of flagellar genes². We agree with other recent reports that future studies would benefit from a detailed examination of the transcriptome, proteome and/or metabolome to better understand the potential impact of probiotics on the gut microbiota, and the mechanism of the effect of BMI. Pfizer Inc. Objectives This exploratory study builds upon an earlier study of probiotic supplementation1 to assess the effects of a probiotic combination (P) of LGG and BB-12 on human gut microbiota composition and function, and to uncover an association with BMI. Methods Healthy subjects ingested P for 21 days (n = 18, P group) or did not (n = 7, C group). Fecal samples obtained at baseline (D_0) and after 21 days of supplementation (D_21) underwent 16S ribosomal RNA gene and shotgun metagenomics sequencing to characterize the bacterial and archaeal communities to the genus/species level and identify functional community genes. Results Following P ingestion, no global differences in microbiota community structure or relative gene abundance were detected. In targeted analyses, the abundances of LGG and BB-12 in the P group at D_21 increased in a statistically significant manner as the BMI decreased (Spearman correlation, P = 0.04 and P = 0.01, respectively). The relative abundance of LGG but not BB-12 appeared increased in P subjects at D_21 with BMI < 25 compared to BMI > 25 (P = 0.09). P group subjects with BMI < 25 demonstrated trends toward or statistically significant increases in the relative abundances of 5 genes involved with flagellar structure (KEGG orthologs K02422, P = 0.04; K03406, P = 0.06; K02407, P = 0.08; K02397, P = 0.08; K02396, P = 0.09) at D_21 compared to those with BMI > 25. No such differences were observed for the C group nor were there differences in relative gene abundance at D_0 in the P group with BMI < 25 vs BMI > 25. Conclusions We observed no global changes in the fecal microbial community structure or function with P ingestion in this sample of healthy persons. However, we did observe patterns suggestive of a potential link between BMI and the response of the gut microbiota to P. Although our results are based on a small number of subjects, they are in line with previous findings related to LGG supplementation and the expression of flagellar genes2. We agree with other recent reports that future studies would benefit from a detailed examination of the transcriptome, proteome and/or metabolome to better understand the potential impact of probiotics on the gut microbiota, and the mechanism of the effect of BMI. Funding Sources Pfizer Inc. ObjectivesThis exploratory study builds upon an earlier study of probiotic supplementation1 to assess the effects of a probiotic combination (P) of LGG and BB-12 on human gut microbiota composition and function, and to uncover an association with BMI.MethodsHealthy subjects ingested P for 21 days (n = 18, P group) or did not (n = 7, C group).Fecal samples obtained at baseline (D_0) and after 21 days of supplementation (D_21) underwent 16S ribosomal RNA gene and shotgun metagenomics sequencing to characterize the bacterial and archaeal communities to the genus/species level and identify functional community genes.ResultsFollowing P ingestion, no global differences in microbiota community structure or relative gene abundance were detected. In targeted analyses, the abundances of LGG and BB-12 in the P group at D_21 increased in a statistically significant manner as the BMI decreased (Spearman correlation, P = 0.04 and P = 0.01, respectively). The relative abundance of LGG but not BB-12 appeared increased in P subjects at D_21 with BMI < 25 compared to BMI > 25 (P = 0.09). P group subjects with BMI < 25 demonstrated trends toward or statistically significant increases in the relative abundances of 5 genes involved with flagellar structure (KEGG orthologs K02422, P = 0.04; K03406, P = 0.06; K02407, P = 0.08; K02397, P = 0.08; K02396, P = 0.09) at D_21 compared to those with BMI > 25. No such differences were observed for the C group nor were there differences in relative gene abundance at D_0 in the P group with BMI < 25 vs BMI > 25.ConclusionsWe observed no global changes in the fecal microbial community structure or function with P ingestion in this sample of healthy persons. However, we did observe patterns suggestive of a potential link between BMI and the response of the gut microbiota to P. Although our results are based on a small number of subjects, they are in line with previous findings related to LGG supplementation and the expression of flagellar genes2. We agree with other recent reports that future studies would benefit from a detailed examination of the transcriptome, proteome and/or metabolome to better understand the potential impact of probiotics on the gut microbiota, and the mechanism of the effect of BMI.Funding SourcesPfizer Inc. This exploratory study builds upon an earlier study of probiotic supplementation to assess the effects of a probiotic combination (P) of LGG and BB-12 on human gut microbiota composition and function, and to uncover an association with BMI. Healthy subjects ingested P for 21 days ( = 18, P group) or did not ( = 7, C group).Fecal samples obtained at baseline (D_0) and after 21 days of supplementation (D_21) underwent 16S ribosomal RNA gene and shotgun metagenomics sequencing to characterize the bacterial and archaeal communities to the genus/species level and identify functional community genes. Following P ingestion, no global differences in microbiota community structure or relative gene abundance were detected. In targeted analyses, the abundances of LGG and BB-12 in the P group at D_21 increased in a statistically significant manner as the BMI decreased (Spearman correlation, = 0.04 and = 0.01, respectively). The relative abundance of LGG but not BB-12 appeared increased in P subjects at D_21 with BMI < 25 compared to BMI > 25 ( = 0.09). P group subjects with BMI < 25 demonstrated trends toward or statistically significant increases in the relative abundances of 5 genes involved with flagellar structure (KEGG orthologs K02422, = 0.04; K03406, = 0.06; K02407, = 0.08; K02397, = 0.08; K02396, = 0.09) at D_21 compared to those with BMI > 25. No such differences were observed for the C group nor were there differences in relative gene abundance at D_0 in the P group with BMI < 25 vs BMI > 25. We observed no global changes in the fecal microbial community structure or function with P ingestion in this sample of healthy persons. However, we did observe patterns suggestive of a potential link between BMI and the response of the gut microbiota to P. Although our results are based on a small number of subjects, they are in line with previous findings related to LGG supplementation and the expression of flagellar genes . We agree with other recent reports that future studies would benefit from a detailed examination of the transcriptome, proteome and/or metabolome to better understand the potential impact of probiotics on the gut microbiota, and the mechanism of the effect of BMI. Pfizer Inc. |
ArticleNumber | nzz040.P20-023-19 |
Author | Stern, Lori Poutsiaka, Debra McDermott, Laura Cope, Julia Kane, Anne Nasser, Waleed Dinh, Duy Snydman, David Hollister, Emily Thorpe, Cheleste Riquelme, Virginia Nassif, Joy |
AuthorAffiliation | 3 Diversigen, Inc 2 Pfizer Consumer Healthcare 1 Tufts Medical Center |
AuthorAffiliation_xml | – name: 1 Tufts Medical Center – name: 2 Pfizer Consumer Healthcare – name: 3 Diversigen, Inc |
Author_xml | – sequence: 1 givenname: Debra surname: Poutsiaka fullname: Poutsiaka, Debra organization: Tufts Medical Center – sequence: 2 givenname: Lori surname: Stern fullname: Stern, Lori organization: Pfizer Consumer Healthcare – sequence: 3 givenname: Virginia surname: Riquelme fullname: Riquelme, Virginia organization: Diversigen, Inc – sequence: 4 givenname: Emily surname: Hollister fullname: Hollister, Emily organization: Diversigen, Inc – sequence: 5 givenname: Julia surname: Cope fullname: Cope, Julia organization: Diversigen, Inc – sequence: 6 givenname: Waleed surname: Nasser fullname: Nasser, Waleed organization: Diversigen, Inc – sequence: 7 givenname: Duy surname: Dinh fullname: Dinh, Duy organization: Diversigen, Inc – sequence: 8 givenname: Joy surname: Nassif fullname: Nassif, Joy organization: Diversigen, Inc – sequence: 9 givenname: Cheleste surname: Thorpe fullname: Thorpe, Cheleste organization: Tufts Medical Center – sequence: 10 givenname: Anne surname: Kane fullname: Kane, Anne organization: Tufts Medical Center – sequence: 11 givenname: Laura surname: McDermott fullname: McDermott, Laura organization: Tufts Medical Center – sequence: 12 givenname: David surname: Snydman fullname: Snydman, David organization: Tufts Medical Center |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31225291$$D View this record in MEDLINE/PubMed |
BookMark | eNqNUltv0zAUjtAQG2M_AWSJl_Yhqy9xEj8wtFYjVOoE4vJsOc4J9UjsEicT3R_j7-EuZYy9DMnyObK_7zvX59GBdRai6CXBpwQLNtOVndmbG5zg048Ux5iymIgn0RFNMh5TIcjBPf8wOvH-CmNMhBApFs-iQ0Yo5VSQo-jXst0o3SNXo7mrtuhSeY-WtoKfaDK_XE6Rs6hfA7qoaxhhCq0CwZVKm6YZPPq0Vq11PnhFgSaropjO5qY21Q7RQ2eGFp1b06rGePR5KP0GtAF_KxJe5vOY0BBqZ6Zo4drSWNWbEDWcYujRpdGdK43rFZr8rXX6Inpaq8bDyd4eR1_fXXxZvI9XH4rl4nwVa5YzcXuTlEEuKkZ4RlOdK1xzKLO0zDmnWV0pUROeJhXJK1byBEoCOgOgoHSK2XF0NupuhrKFSoPtO9XITRcq6rbSKSP__bFmLb-5a5nyLE_SLAhM9gKd-zGA72VrvIamURbc4CVljBOaCryL9foB9MoNnQ3lyVCESATNMQmoV_czukvlz0wDgI-A0DjvO6jvIATL3frIsD5yXB8ZWipDSyURgYdHnhs2j1D2UwiUtyMFwgiuDXTSh-FaDZXpwrrIyplHg755oKAbY41WzXfY_gf_Nzpq70c |
ContentType | Journal Article |
Copyright | 2019 American Society for Nutrition. Copyright © American Society for Nutrition 2019. 2019 Copyright © American Society for Nutrition 2019. |
Copyright_xml | – notice: 2019 American Society for Nutrition. – notice: Copyright © American Society for Nutrition 2019. 2019 – notice: Copyright © American Society for Nutrition 2019. |
DBID | 6I. AAFTH AAYXX CITATION NPM 3V. 7RV 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. KB0 M0S NAPCQ PHGZM PHGZT PIMPY PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7S9 L.6 5PM |
DOI | 10.1093/cdn/nzz040.P20-023-19 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | AGRICOLA Publicly Available Content Database PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
DocumentTitleAlternate | Nutrition 2019 Abstracts |
EISSN | 2475-2991 |
ExternalDocumentID | PMC6578467 31225291 10_1093_cdn_nzz040_P20_023_19 10.1093/cdn/nzz040.P20-023-19 S2475299123151183 |
Genre | Journal Article |
GroupedDBID | .1- .FO 0R~ 7RV 7X7 8FI 8FJ AAFWJ AAHBH AALRI AAPXW AAVAP AAXUO AAYWO ABPTD ABUWG ABXVV ACGFS ACVFH ADBBV ADCNI ADVLN AEUPX AFJKZ AFKRA AFPKN AFPUW AFRHN AIGII AITUG AJUYK AKBMS AKYEP ALMA_UNASSIGNED_HOLDINGS AMNDL AMRAJ AOIJS APXCP BAYMD BCNDV BENPR CCPQU EBS EJD EMOBN FDB FYUFA GROUPED_DOAJ H13 HMCUK HYE IAO IHR INH ITC KSI M~E NAPCQ O9- OK1 PHGZM PHGZT PIMPY PPXIY PUEGO RPM UKHRP Z5R 0SF 6I. AAFTH ABDBF AFULF BTTYL ROX TOX AAYXX CITATION ABEJV ABGNP NPM 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQQKQ PQUKI PRINS 7S9 L.6 5PM |
ID | FETCH-LOGICAL-c3839-c383163e89d315726c8a0f5eb76b85527fda9f1564d18d3b54eb1ec7ee2eac603 |
IEDL.DBID | 7X7 |
ISSN | 2475-2991 |
IngestDate | Thu Aug 21 14:07:18 EDT 2025 Fri Jul 11 07:41:56 EDT 2025 Fri Jul 25 09:17:53 EDT 2025 Mon Mar 03 18:06:47 EST 2025 Tue Jul 01 01:04:28 EDT 2025 Mon Jun 30 08:34:46 EDT 2025 Sat Jul 20 16:35:13 EDT 2024 Tue Aug 26 16:34:19 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | Supplement_1 |
Language | English |
License | http://creativecommons.org/licenses/by-nc-nd/4.0 This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3839-c383163e89d315726c8a0f5eb76b85527fda9f1564d18d3b54eb1ec7ee2eac603 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/3169492801?pq-origsite=%requestingapplication% |
PMID | 31225291 |
PQID | 3169492801 |
PQPubID | 7121353 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6578467 proquest_miscellaneous_2335126900 proquest_journals_3169492801 pubmed_primary_31225291 crossref_primary_10_1093_cdn_nzz040_P20_023_19 oup_primary_10_1093_cdn_nzz040_P20-023-19 elsevier_sciencedirect_doi_10_1093_cdn_nzz040_P20_023_19 elsevier_clinicalkey_doi_10_1093_cdn_nzz040_P20_023_19 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-Jun |
PublicationDateYYYYMMDD | 2019-06-01 |
PublicationDate_xml | – month: 06 year: 2019 text: 2019-Jun |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Oxford |
PublicationTitle | Current developments in nutrition |
PublicationTitleAlternate | Curr Dev Nutr |
PublicationYear | 2019 |
Publisher | Elsevier Inc Oxford University Press |
Publisher_xml | – name: Elsevier Inc – name: Oxford University Press |
SSID | ssj0001999609 |
Score | 2.0696068 |
Snippet | This exploratory study builds upon an earlier study of probiotic supplementation1 to assess the effects of a probiotic combination (P) of LGG and BB-12 on... ObjectivesThis exploratory study builds upon an earlier study of probiotic supplementation1 to assess the effects of a probiotic combination (P) of LGG and... This exploratory study builds upon an earlier study of probiotic supplementation to assess the effects of a probiotic combination (P) of LGG and BB-12 on human... Objectives This exploratory study builds upon an earlier study of probiotic supplementation1 to assess the effects of a probiotic combination (P) of LGG and... This exploratory study builds upon an earlier study of probiotic supplementation¹ to assess the effects of a probiotic combination (P) of LGG and BB-12 on... |
SourceID | pubmedcentral proquest pubmed crossref oup elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | nzz040.P20-023-19 |
SubjectTerms | Archaea Bifidobacterium animalis Body mass index community structure feces Genes Gut microbiota intestinal microorganisms Lactobacillus rhamnosus metabolome metagenomics microbial communities Microbiota Nutritional Microbiology Probiotics proteome ribosomal RNA transcriptome |
Title | Impact of Body Mass Index (BMI) on the Effect of a Lactobacillus Rhamnosus GG (LGG)/Bifidobacterium Animalis Subspecies Lactis BB-12 (BB-12) Combination on Gut Microbiota (P20-023-19) |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S2475299123151183 https://dx.doi.org/10.1093/cdn/nzz040.P20-023-19 https://www.ncbi.nlm.nih.gov/pubmed/31225291 https://www.proquest.com/docview/3169492801 https://www.proquest.com/docview/2335126900 https://pubmed.ncbi.nlm.nih.gov/PMC6578467 |
Volume | 3 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLZge-EFAeOSbVRGQqh5yJqrEz-hBm1Z0TpNE5P6ZjlxokVanbE0D9sf4-9xTi7tihDjpa0aO3bj0-98ts_5TMjnInQzVzFpSeAWFuqXWCmAoCUzPwX-EUjfwUTh-Tk7vfK_L4JFv-BW92GVAya2QK2qDNfIJ57DuM9dANSvtz8tPDUKd1f7IzSek12ULsOQrnARbtZYkM3bfEjc4d4kU3qiHx7Aco8uYN4EDstCjZ2_u6StjLdHxPPP-MlHDunkFXnZM0k67Yb-NXmW6zdkb6phFr28p19oG9vZLprvkV-zNhmSVgWNK3VP50CZ6QyFEuk4ns9MWmkKTJB2WsZYTNIzPIknlVl5c9PU9PJaLnVVw6ckoeOzJDEncVmUCkug3HOzpFNdLlFOkSIY4bH2ed3eBL6JY8txoSl8MylgEMzHW5PAhpNmRedlJwi1knS8eWTmW3J1cvzj26nVH9lgZTDV5e0rMLw84spzgtBlWSTtIsjTkKURir0VSvICBWqUEykvDXzwFXkW5rkLHoDZ3juyoyudfyA0UkWUMT-E-aPrw49P_SxyU6CvoQx9FiiDHA2jJm47ZQ7R7ah7AoZZdMMsoM8C-iwcbhA2jK0Y0k4BKAX4jqcqRuuKPS_p-Mb_VDXBiJ7oX_9MDXI4mJrogaQWG7M3yKf1ZYAA3NeROq-aWrieB7SNcds2yPvOMtcteg4Atsuhdrhls-sCKC--fUWX163MOAMwBze6_-9uHZAXwCF5Fz13SHZWd03-EXjaKh21f8YR2Y2Pzy8uR-1qx2-eqDsb |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Pb9MwFLZGd4ALGowfZQOMBKg9ZG2cxIkPCDWwtWVtNU2btJtx4kSLtDqFtELdH8WVf4_nOGlXhBiXXdoqsWM37_l737P9nhF6m_okJpIKSwC3sHT-EisCELRE7EbAPzzh2jpQeDyhg3P3y4V3sYV-1rEweltljYklUMs81nPkHcemzGUEAPXj7JulT43Sq6v1ERpGLY6T5Q9w2YoPw88g33eEHB2efRpY1akCVgzeGCs_gYQkAZOO7fmExoHopl4S-TQKdD6yVAqW6hwq0g6kE3kuwFkS-0lCAKRo14Hn3kPbrgOuTANth4eTk9P1rI72H7qsDhViTieWqqOur2GsHJyApwYm0tJZff5uBDdi7G5Q3T93bN4wgUc76GHFXXHPKNsjtJWox2i3p8Bvny7xe1zuJi2n6XfRr2EZfonzFIe5XOIxkHQ81KkZcSscD9s4Vxi4JzbZk3UxgUf67J9IxNnV1aLAp5diqvICfvX7uDXq99udMEszqUvoBNOLKe6pbKoTOGINf7MEYKooHwJXwtCyCTSlv9oYUC_KzLynbri_mONxZlJQzQVurV9Z-wk6vxNxPkUNlavkOcKBTIOYuj54rMSFPx-5cUAiIMy-8F3qySY6qKXGZyYXCDdr-A4HMXMjZg595tBnbrMmorVseR3oCtDMwVrdVjFYVayYkGE4_1O1DUp0S_-qd9pE-7Wq8Qq6Cr4eaE30ZnUbQEevJAmV5IuCE8cBokhZt9tEz4xmrlp0bDARhEFtf0NnVwV0QvPNOyq7LBObUzAfYLhf_Ltbr9H9wdl4xEfDyfEeegAMlpm9e_uoMf--SF4CS5xHr6qhidHXu0aD3_TbdpU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+Body+Mass+Index+%28BMI%29+on+the+Effect+of+a+Lactobacillus+Rhamnosus+GG+%28LGG%29%2FBifidobacterium+Animalis+Subspecies+Lactis+BB-12+%28BB-12%29+Combination+on+Gut+Microbiota+%28P20-023-19%29&rft.jtitle=Current+developments+in+nutrition&rft.au=Poutsiaka%2C+Debra&rft.au=Stern%2C+Lori&rft.au=Riquelme%2C+Virginia&rft.au=Hollister%2C+Emily&rft.date=2019-06-01&rft.pub=Elsevier+Inc&rft.issn=2475-2991&rft.eissn=2475-2991&rft.volume=3&rft_id=info:doi/10.1093%2Fcdn%2Fnzz040.P20-023-19&rft.externalDocID=S2475299123151183 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2475-2991&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2475-2991&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2475-2991&client=summon |